MLB to question Dodgers team doctor ElAttrache over alleged McGregor PED involvement

What happened

MLB is expected to question Neal ElAttrache, the team doctor for the Los Angeles Dodgers and the NFL's Los Angeles Rams, regarding his alleged involvement in performance-enhancing drug use by mixed martial artist Conor McGregor, per CBS Sports. The report does not describe the questioning as a formal disciplinary proceeding, and no findings, charges, or conclusions have been reported against ElAttrache.

The scope of the inquiry, as CBS Sports describes it, is limited to questioning — not a suspension, not a termination, and not a ruling of any kind. That distinction is worth holding onto carefully as this story develops, because the distance between "will be questioned" and "has been found to have done something wrong" is considerable, and CBS Sports does not close that gap.

Why it matters

ElAttrache's role as the Dodgers' team doctor places him at the center of the organization's medical infrastructure — the person whose judgment shapes how the club evaluates, treats, and returns its players from injury. That position carries institutional weight that extends well beyond any one patient or any one sport, which is presumably why MLB's interest extends beyond the competitive arena where its authority is clearest.

The alleged conduct at issue involves Conor McGregor, a figure entirely outside MLB's competitive jurisdiction. McGregor is not a baseball player, is not affiliated with any MLB club, and is not subject to the league's joint drug program. The league's apparent interest, per CBS Sports, is in ElAttrache's conduct as a physician — specifically whether that conduct, if the allegations have merit, is consistent with the standards MLB expects of medical personnel associated with its clubs.

It is worth being precise about what CBS Sports does and does not report. The outlet reports that MLB will question ElAttrache. It does not report that MLB has concluded he did anything wrong, that the Dodgers have taken any action, or that ElAttrache's role with the club is in any way in jeopardy. Those remain open questions, and the desk will treat them as such.

Is this an MLB disciplinary matter?

Not as CBS Sports describes it — at least not yet. The report frames what is coming as questioning, which is a step in a process rather than a conclusion of one. Whether that questioning leads to a formal investigation, a referral, or any kind of finding is not reported. CBS Sports also does not address what authority, if any, MLB holds over a team physician's conduct with clients who have no connection to professional baseball. That is a genuinely interesting jurisdictional question, and the desk will leave it to the lawyers while noting that the league apparently believes it has enough standing to ask.

The McGregor angle adds a layer of institutional novelty here. MLB's drug program governs players on 40-man rosters and affiliated personnel in defined roles. A physician treating a combat sports figure in a private capacity sits in murkier territory, and how the league navigates that boundary — if it chooses to navigate it at all beyond the questioning stage — will be one of the more procedurally interesting things to watch as this develops.

Where the club stands

Whatever the front office is managing off the field this week, the Dodgers are doing it from a position of considerable on-field comfort. Los Angeles sits at 100-62 (.617), first in the NL West and leading the division, riding a three-game winning streak into a weekend series at Rate Field against the Chicago White Sox.

The schedule sets up as follows: Friday brings Roki Sasaki against Anthony Kay, Saturday sends Yoshinobu Yamamoto to the mound opposite Sean Burke, and Sunday closes the series with Emmet Sheehan facing Bryan Hudson. It is, on paper, a favorable draw — though the desk notes that Rate Field has a way of humbling the overconfident, and the White Sox have their own reasons to play hard regardless of what the standings say.

A record of 100-62 is the kind of number that tends to insulate an organization from short-term turbulence. The Dodgers have built enough margin that a distraction in the medical office, however it resolves, is unlikely to alter the competitive calculus of the next three games. The longer-term institutional question — what this inquiry means for ElAttrache's standing and for the club's medical operations — is a different matter entirely, and one that will take considerably more time to answer.

What we don't know yet

CBS Sports leaves several material facts unresolved, and the desk is not in the business of filling gaps with inference.

It is not reported what specific allegations prompted the inquiry, what evidence MLB is working from, or what the timeline of the alleged conduct is. It is not reported whether the Dodgers organization was notified in advance of the inquiry, whether ElAttrache has responded publicly or through counsel, or what MLB's internal process looks like once the questioning is complete. It is not reported whether any formal investigation — as distinct from questioning — has been opened or is contemplated.

The report also does not address what the Dodgers themselves make of the situation. The club has not been quoted, and CBS Sports does not indicate that the organization has commented. The desk will not put words in their mouth.

One further gap worth naming: the nature of the alleged PED use attributed to McGregor is not detailed in the CBS Sports report. The desk knows only that the allegation exists and that MLB's interest in ElAttrache is connected to it. Everything downstream of that is speculation, and the desk does not traffic in speculation.

What to watch

The immediate question is whether MLB's questioning of ElAttrache produces any formal finding, referral, or public statement from the league. CBS Sports frames the questioning as something MLB "will" do, which means the next meaningful development is whatever the league says — or does not say — once that process runs its course.

Also worth monitoring is whether the Dodgers organization makes any statement about ElAttrache's status or their own review of the situation. If the organization moves to distance itself from the situation, or conversely reaffirms its confidence in ElAttrache, that will be a meaningful data point. Silence, too, can be informative, though the desk is careful not to read too much into it.

The McGregor angle bears watching in its own right. The alleged PED use is not an MLB matter in any competitive sense, but if legal or regulatory proceedings in another jurisdiction produce findings, those findings could inform whatever MLB is examining here. The two tracks — MLB's inquiry and any proceedings involving McGregor — are separate, but they are not entirely unrelated, and movement on one could accelerate movement on the other.

The Dodgers, for their part, will take the field Friday at Rate Field with a 100-62 record and a three-game winning streak. Baseball has a useful way of continuing regardless of what is happening in the conference rooms. The desk will keep an eye on both.